Lateral Flow IgE Immunoassay Apparatus
Research ownership & attribution: Rami M. Alkhaleeli — Alkhaleeli BioAI LLC
Scientific Concept
This documented invention concept (USPTO provisional application 63/931,575, receipt date December 5, 2025) focuses on a rapid lateral-flow immunoassay apparatus for detecting and estimating allergen-specific IgE antibodies. The goal is to support fast, accessible allergy-related screening research using a portable test format.
Scientific Diagram
Scientific diagram not provided for this case. The documented analysis is presented in the sections below.
Design Process
- 1
Assay format definition — lateral-flow strip format for allergen-specific IgE detection.
- 2
Capture chemistry concept — immobilized allergen targets on the test line.
- 3
Detection and estimation concept — signal intensity related to IgE level (research format).
- 4
Portable device concept — low-cost, point-of-need test format.
Proposed Biological Mechanism
- 1
The sample migrates along the lateral-flow strip.
- 2
Allergen-specific IgE binds immobilized allergen targets on the test line.
- 3
A visible signal indicates detection; the research concept proposes estimating IgE levels (proposed — no performance results are claimed).
All steps describe intended, modeled or proposed behavior — no effect above is experimentally proven or clinically demonstrated.
Mathematical Analysis
No numerical performance values are documented for this concept-stage filing.
FASTA Sequence Viewer
Complete sequence not available
Complete sequence not available in the supplied manuscript. Sequences are never generated as replacements — the original sequence files remain private until the author authorizes public access.
Original Scientific Manuscript
Manuscript — Private by default
The filing document is kept private by default. Development stage: documented USPTO provisional application 63/931,575.
Request manuscript access via the collaboration contactScientific Status
Lateral Flow IgE Immunoassay Apparatus — Documented provisional filing
These projects are scientific research designs and computational proof-of-concept studies. They are not approved medical products, experimentally validated cures, or guarantees of therapeutic effectiveness.